肺癌
医学
肿瘤科
突变体
内科学
癌症研究
生物
基因
遗传学
作者
Si‐Yang Maggie Liu,Tatiana Erazo,Justin Jee,Andrea Arfè,Avantika Gupta,Luke Pike,Fernando C. Santini,Bobby Daly,Adam J. Schoenfeld,Jordan Eichholz,Kaylie Johnson,Andrés Martinez,Jane Sze Yin Sui,Nadeem Riaz,Jason C. Chang,Soo‐Ryum Yang,William D. Travis,Maria E. Arcila,Jiannan Guo,Éric Gagné
标识
DOI：10.1016/j.ejca.2024.114257
摘要
No definitive answers currently exist regarding optimal first-line therapy for HER2-mutant NSCLC. Access to rapid tissue sequencing is a major barrier to precision drug development in the first-line setting. ctDNA analysis has the potential to overcome these obstacles and guide treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
浮游
核桃
Singularity
遇上就这样吧
辛勤的诗柳
带头大哥
不安青牛
今天只做一件事
彭于彦祖
Maestro_S
pcr163
小乐
pluto
zho
GIINJIU
个性的紫菜
DijiaXu
LaTeXer
eric888
子车茗
浮浮世世
yznfly
CR7
GingerF
小青椒
8R60d8
司空豁
兔子
皖公网安备34019202002308
